[1] Parkin D M, Bray F, Ferlay J, et al. Estimating the world cancer burden: globocan 2000[J]. Intl J Cancer,2001,94(2):153
[2] 刘继红,李玉洁.我国宫颈癌预防面临的机遇和挑战[J].中国肿瘤,2010,19(7):424
[3] 连利娟.林巧稚妇科肿瘤学[M].北京:人民卫生出版社,2008:312-313
[4] 周静,李力.宫颈癌根治术后尿潴留的原因及预防护理进展[J].重庆医学,2012,41(15):1545
[5] 纪妹,单家治.宫颈癌广泛性子宫切除术后尿潴留防治临床观察[J].中国误诊学杂志,2007,7(2):230
[6] Kobayashi T, Inoue S. Lymphatic cyst seen after radical hysterectomy for cancer of the uterine cervix and its significance[J]. ClinGynecol Obstet, 1950, 4: 91
[7] Averette H E, Hudson R C, Ferguson H J. Lymphangioadenography: applications in the study and management of gynecologic cancer[J]. Cancer, 1964, 17: 1093
[8] 戚世芳,付改玲.子宫颈癌根治术后盆腔淋巴囊肿25例分析[J].中国实用妇科与产科杂志,2006,11(22):835
[9] Suzuki M, Ohwada M, Sato I. Pelvic lymphocysts following retroperitoneal lymphadenectomy: retroperitoneal partial“no-closure”for ovarian and endometrial cancers[J]. J Surg Oncol, 1998, 68(3): 149
[10] 张红菊,刘玉.经阴道低负压引流器预防宫颈癌根治术后盆腔淋巴囊肿形成的研究[J].护士进修杂志,2007,7(22):1279
[11] 王建六,宫颈癌卵巢移位术后盆腔放疗对卵巢功能的影响[J].中国实用妇科与产科杂志,2006,22(8):579
[12] Pahisa J, Martinez-Roman S, Martinez-Zamora M A, et al. Laparoscopic ovarian transposition in patients with early cervical cancer[J].Int J Gynecol Cancer,2008,18(3):584
[13] 吴绪峰,陈慧祯.降低宫颈癌根治术后并发症的技术改进[J].中国肿瘤临床,2001,28(9):645
[14] 曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2010:589-590
[15] 蔡淑香,金卓杏,等.宫颈癌光发型子宫切除加盆腔淋巴结清扫手术方式的探讨[J].中国实用妇科与产科杂志,2008,24(1):67
[16] 程玺,蔡树模,李子庭.宫颈癌根治术后盆腔淋巴结转移的预后研究[J].癌症, 2003,22(11):1219
[1]崔丽阳,岳天孚.高危型HPV持续感染的影响因素探讨[J].天津医科大学学报,2014,20(03):209.
CUI Li-yang,YUE Tian-fu.Investigation on factors for persistent high-risk human papilloma virus infection[J].Journal of Tianjin Medical University,2014,20(01):209.
[2]孙 艳,齐 政,王德华,等.miR-186通过靶定CEA抑制宫颈癌细胞转移[J].天津医科大学学报,2016,22(04):288.
SUN Yan,QI Zheng,WANG De-hua,et al.miR-186 inhibits cervical cancer migration by targetting CEA[J].Journal of Tianjin Medical University,2016,22(01):288.
[3]李 娜,李洪林,尹利荣.HPV E6/E7 mRNA与YAP在宫颈癌中的表达与相关性研究[J].天津医科大学学报,2018,24(04):307.
LI Na,LI Hong-lin,YIN Li-rong.HPV E6/E7 mRNA and YAP expression and their correlation in cervical carcinoma[J].Journal of Tianjin Medical University,2018,24(01):307.
[4]曲首辉,鲍志敏,刘荣欣.TCT、活检病理在宫颈上皮瘤变及早期宫颈癌诊断中的价值分析[J].天津医科大学学报,2018,24(04):360.
[5]陈 辉,樊茹佳,丁继侠.宫颈癌组织中Foxm1、ANGPTL4蛋白表达及临床意义[J].天津医科大学学报,2019,25(05):510.
CHEN Hui,FAN Ru-jia,DING Ji-xia.Expression and clinical significance of Foxm1 and ANGPTL4 protein in cervical cancer tissues[J].Journal of Tianjin Medical University,2019,25(01):510.
[6]闫晓芳,谢 虹,汤 华.miR-3685通过靶向CTTN抑制宫颈癌细胞的迁移、侵袭及生长[J].天津医科大学学报,2020,26(01):8.
YAN Xiao-fang,XIE Hong,TANG Hua.miR-3685 inhibits migration, invasion and growth of cervical cancer cells by targeting CTTN[J].Journal of Tianjin Medical University,2020,26(01):8.
[7]白丽丽,汤华.TNF-α诱导的circMAN1A2促进宫颈癌细胞的迁移、侵袭和增殖[J].天津医科大学学报,2020,26(02):103.
BAI Li-li,TANG Hua.TNF-α-induced circMAN1A2 promotes migration, invasion and proliferation of cervical cancer cells[J].Journal of Tianjin Medical University,2020,26(01):103.
[8]赵敬,杨金豪,张文帆,等.2009—2020年中国女性生殖道支原体、衣原体和人乳头瘤病毒感染与宫颈癌发生相关性的Meta分析[J].天津医科大学学报,2021,27(04):396.
ZHAO Jing,YANG Jin-hao,ZHANG Wen-fan,et al.A meta-analysis of association between Mycoplasma,Chlamydia infection and Human papillomavirus infection in female genital tract and cervical cancer in China from 2009 to 2020[J].Journal of Tianjin Medical University,2021,27(01):396.
[9]赵敬,杨金豪 综述,常艳敏,等.中国宫颈癌DNA甲基化标志物的研究进展[J].天津医科大学学报,2021,27(05):545.
[10]李广宁 综述,曹文枫 审校.女性生殖系统双原发癌的研究进展[J].天津医科大学学报,2021,27(06):655.